Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Thromboseprophylaxe Mit Niedermolekularem Heparin Bei Transurethralen Eingriffen

Trial Profile

Thromboseprophylaxe Mit Niedermolekularem Heparin Bei Transurethralen Eingriffen

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Apr 2009

At a glance

  • Drugs Dalteparin sodium (Primary)
  • Indications Thrombosis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 30 Apr 2009 Results presented at the American Urological Association Annual Meeting (AUA) 2009.
    • 19 Mar 2009 Results reported at the 24th Annual Congress of the European Association of Urology (EAU), 2009.
    • 12 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top